Search results
Results from the WOW.Com Content Network
Question 2 measures the reliability of the study. If it is an intervention study, reliability consists of: whether the intervention worked, how large the effect was, and whether a clinician could repeat the study with similar results. If it is a qualitative study, reliability would be measured by determining if the research accomplished the ...
Although much of nursing ethics can appear similar to medical ethics, there are some factors that differentiate it. Breier-Mackie [5] suggests that nurses' focus on care and nurture, rather than cure of illness, results in a distinctive ethics. Furthermore, nursing ethics emphasizes the ethics of everyday practice rather than moral dilemmas. [2]
A commonly used measure of ethical leadership is the Ethical Leadership Scale (ELS), developed by Brown et al. in 2005. It consists of 10 items with an internal consistency of alpha = .92 and shows a satisfying fit, with indices at or above recommended standards. [ 1 ]
Increased emphasis on self-care: Self-care is so important to nurses' overall well-being that the American Nurses Association mandates care of oneself in its Code of Ethics.
Karen C. Johnson is the chair for the Department of Preventive Medicine at the University of Tennessee Health Science Center (UTHSC). [1] She has been involved in at least five clinical world trials, including a Women's health initiative, the SPRINT Trial, the Look AHEAD (Action for Health in Diabetes) Study, the TARGIT Study and the D2d Trial.
This study is based on a 5,504-person online survey, which included 5,000 18-to-65-year-old respondents in the top 50 metropolitan areas (100 respondents per city) and a nationally representative ...
Managing complex business models effectively depends on leadership that can make dynamic decisions, build commitment to specific visions and goals, learn actively at multiple levels, and engage conflict. [11] On the group level of analysis, scholars have examined how team members affect leadership actions in the promotion of ambidexterity.
Another goal for the coming year was to “maximize and grow Risperdal’s market leadership in geriatrics and long term care.” Risperdal was already well ahead of Zyprexa in dementia market share, with 50 percent of the entire market. The goal was to boost that share still higher, to 57 percent, with sales of $302 million.